Zobrazeno 1 - 10
of 2 222
pro vyhledávání: '"Settore MED/40 - GINECOLOGIA E OSTETRICIA"'
Autor:
Panagiotis Peitsidis, Panagiotis Tsikouras, Antonio Simone Laganà, Alexandros Laios, Ioannis D Gkegkes, Christos Iavazzo
Publikováno v:
Drug Design, Development and Therapy. 17:1329-1346
Endometriosis is a chronic gynecologic condition that affects around 6-10% of reproductive age women. This clinical entity is characterized with pelvic pain, dysmenorrhea, dyspareunia, and infertility which are the most often presenting symptoms. Aro
Autor:
Musacchio, Lucia, Turinetto, Margherita, Arenare, Laura, Bartoletti, Michele, Califano, Daniela, Tuninetti, Valentina, Marchetti, Claudia, Cormio, Gennaro, Loizzi, Vera, Pisano, Carmela, Salutari, Vanda, Valabrega, Giorgio, Priolo, Domenico, Cecere, Sabrina Chiara, Ventriglia, Jole, Raspagliesi, Francesco, Perrone, Francesco, Fagotti, Anna, Lorusso, Domenica, Scambia, Giovanni, Pignata, Sandro
Publikováno v:
Gynecologic Oncology. 172:72-77
Pravastatin for severe preeclampsia with growth restriction: Placental findings and infant follow-up
Autor:
Fruci, S., Salvi, Silvia, Moresi, Sascia, Gallini, Francesca, Dell'Aquila, Marco, Arena, Vincenzo, Di Stasio, Enrico, Ferrazzani, Sergio, De Carolis, Sara, Lanzone, Antonio
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 283:37-42
Autor:
Thomas J. Herzog, Sandro Pignata, Sharad A. Ghamande, Maria-Jesús Rubio, Keiichi Fujiwara, Christof Vulsteke, Deborah K. Armstrong, Jalid Sehouli, Robert L. Coleman, Hani Gabra, Giovanni Scambia, Bradley J. Monk, José A. Arranz, Kimio Ushijima, Rabbie Hanna, Claudio Zamagni, Robert M. Wenham, Antionio González-Martín, Brian Slomovitz, Yan Jia, Lisa Ramsay, Krishnansu S. Tewari, Susan C. Weil, Ignace B. Vergote
Publikováno v:
Gynecologic oncology
Objective. The primary purpose of this study was to determine if farletuzumab, an antifolate receptor-alpha monoclonal antibody, improved progression-free survival (PFS) versus placebo when added to standard chemo-therapy regimens in patients with pl
Autor:
Cibula, David, Akilli, Huseyin, Jarkovsky, Jiri, van Lonkhuijzen, Luc, Scambia, Giovanni, Meydanli, Mehmet Mutlu, Ortiz, David Isla, Falconer, Henrik, Abu-Rustum, Nadeem R., Odetto, Diego, Klát, Jaroslav, dos Reis, Ricardo, Zapardiel, Ignacio, di Martino, Giampaolo, Presl, Jiri, Laky, Rene, López, Aldo, Weinberger, Vit, Obermair, Andreas, Pareja, Rene, Poncová, Renata, Mom, Constantijne, Bizzarri, Nicolò, Borčinová, Martina, Aslan, Koray, Salcedo Hernandez, Rosa Angélica, Fons, Guus, Benešová, Klára, Dostálek, Lukáš, Ayhan, Ali
Publikováno v:
Gynecologic Oncology, 170, 195-202. Academic Press Inc.
Gynecologic oncology, 170, 195-202. Academic Press Inc.
Cibula, D, Akilli, H, Jarkovsky, J, van Lonkhuijzen, L, Scambia, G, Meydanli, M M, Ortiz, D I, Falconer, H, Abu-Rustum, N R, Odetto, D, Klát, J, dos Reis, R, Zapardiel, I, di Martino, G, Presl, J, Laky, R, López, A, Weinberger, V, Obermair, A, Pareja, R, Poncová, R, Mom, C, Bizzarri, N, Borčinová, M, Aslan, K, Salcedo Hernandez, R A, Fons, G, Benešová, K, Dostálek, L & Ayhan, A 2023, ' Role of adjuvant therapy in intermediate-risk cervical cancer patients – Subanalyses of the SCCAN study ', Gynecologic Oncology, vol. 170, pp. 195-202 . https://doi.org/10.1016/j.ygyno.2023.01.014
Gynecologic oncology, 170, 195-202. Academic Press Inc.
Cibula, D, Akilli, H, Jarkovsky, J, van Lonkhuijzen, L, Scambia, G, Meydanli, M M, Ortiz, D I, Falconer, H, Abu-Rustum, N R, Odetto, D, Klát, J, dos Reis, R, Zapardiel, I, di Martino, G, Presl, J, Laky, R, López, A, Weinberger, V, Obermair, A, Pareja, R, Poncová, R, Mom, C, Bizzarri, N, Borčinová, M, Aslan, K, Salcedo Hernandez, R A, Fons, G, Benešová, K, Dostálek, L & Ayhan, A 2023, ' Role of adjuvant therapy in intermediate-risk cervical cancer patients – Subanalyses of the SCCAN study ', Gynecologic Oncology, vol. 170, pp. 195-202 . https://doi.org/10.1016/j.ygyno.2023.01.014
Objective: The “intermediate-risk” (IR) group of early-stage cervical cancer patients is characterized by negative pelvic lymph nodes and a combination of tumor-related prognostic risk factors such as tumor size ≥2 cm, lymphovascular space inva
Autor:
Péter Török, Antoine Naem, Szilvia Csehely, Vito Chiantera, Zaki Sleiman, Antonio Simone Laganà
Publikováno v:
Minimally Invasive Therapy & Allied Technologies. 32:127-135
Background: The management of ectopic pregnancy is widely debated. Salpingectomy, salpingostomy, and expectant management are widely performed, but the best approach in terms of keeping good future spontaneous fertility chances is yet to be determine
Autor:
Daniela Casati, Mariano Lanna, Chiara Mando', Alice Zavatta, Leonardo Nelva Stellio, Stefano Faiola, Arianna Laoreti, Gaia Maria Anelli, Irene Cetin
Publikováno v:
Placenta. 132:7-14
Monochorionic twins (MC) develop under unique intrauterine conditions and show a high risk of compromise during fetal life. Here we describe umbilical vein blood flow (UVBF) and fetal oxygen and glucose utilization in uncomplicated MC twins and inves
Publikováno v:
Climacteric. 26:149-153
Autor:
Camilla, Di Dio, Giorgio, Bogani, Violante, Di Donato, Ilaria, Cuccu, Ludovico, Muzii, Lucia, Musacchio, Giovanni, Scambia, Domenica, Lorusso
Publikováno v:
Gynecologic Oncology. 169:27-33
Endometrial cancer is the most common gynecological disease in developed countries. Although it is considered an indolent disease, advanced and recurrent endometrial carcinomas are characterized by poor prognosis. In the metastatic setting, after the
Autor:
Luigi Carlo Turco, Luigi Pedone Anchora, Camilla Fedele, Frediano Inzani, Alessia Piermattei, Maurizio Martini, Mariaconcetta Volpe, Simona Marchetti, Rosaria Santangelo, Nicolò Bizzarri, Francesco Cosentino, Virginia Vargiu, Maria De Ninno, Gabriella Macchia, Vincenzo Valentini, Gianfranco Zannoni, Giovanni Scambia, Gabriella Ferrandina
Publikováno v:
International Journal of Gynecologic Cancer. 33:489-497
ObjectiveWhile human papillomavirus (HPV) has been shown to play a significant role in cervical cancer carcinogenesis (HPV associated cases), a considerable percentage of cervical cancers occur independently of HPV status (HPV independent).MethodsIn